IFNAR1 and neoplasm: Taken together with the finding that Ifnar1-deficient mice treated with β-glucan failed to train granulopoiesis to repress tumor growth, these results suggest that β-glucan promotes anti-tumor activity through epigenetic changes in granulopoiesis that are dependent on IFN-I signaling.